Oric Pharmaceuticals Stock Buy Hold or Sell Recommendation
| ORIC Stock | USD 9.59 0.47 5.15% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Oric Pharmaceuticals is 'Sell'. Macroaxis provides Oric Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ORIC positions.
Check out Oric Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide. In addition, we conduct extensive research on individual companies such as Oric and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Oric Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Oric |
Execute Oric Pharmaceuticals Buy or Sell Advice
The Oric recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oric Pharmaceuticals. Macroaxis does not own or have any residual interests in Oric Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oric Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Oric Pharmaceuticals Trading Alerts and Improvement Suggestions
| Oric Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oric Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (100.7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Oric Pharmaceuticals currently holds about 227.06 M in cash with (85.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Oric Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Over 91.0% of the company shares are owned by institutional investors |
Oric Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oric analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oric analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Oric Pharmaceuticals Returns Distribution Density
The distribution of Oric Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Oric Pharmaceuticals' future price movements. The chart of the probability distribution of Oric Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Oric Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oric Pharmaceuticals returns is essential to provide solid investment advice for Oric Pharmaceuticals.
| Mean Return | -0.02 | Value At Risk | -5.18 | Potential Upside | 5.64 | Standard Deviation | 3.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oric Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oric Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oric Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oric Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oric stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 1.93 | |
σ | Overall volatility | 3.82 | |
Ir | Information ratio | -0.04 |
Oric Pharmaceuticals Volatility Alert
Oric Pharmaceuticals exhibits very low volatility with skewness of -0.67 and kurtosis of 2.08. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Oric Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Oric Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Oric Pharmaceuticals Fundamentals Vs Peers
Comparing Oric Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oric Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Oric Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oric Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Oric Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oric Pharmaceuticals to competition |
| Fundamentals | Oric Pharmaceuticals | Peer Average |
| Return On Equity | -0.46 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Current Valuation | 374.32 M | 16.62 B |
| Shares Outstanding | 70.57 M | 571.82 M |
| Shares Owned By Insiders | 9.12 % | 10.09 % |
| Shares Owned By Institutions | 90.88 % | 39.21 % |
| Number Of Shares Shorted | 11.65 M | 4.71 M |
| Price To Book | 2.35 X | 9.51 X |
| EBITDA | (109.75 M) | 3.9 B |
| Net Income | (100.7 M) | 570.98 M |
| Cash And Equivalents | 227.06 M | 2.7 B |
| Cash Per Share | 5.74 X | 5.01 X |
| Total Debt | 10.21 M | 5.32 B |
| Debt To Equity | 0.05 % | 48.70 % |
| Current Ratio | 18.72 X | 2.16 X |
| Book Value Per Share | 3.88 X | 1.93 K |
| Cash Flow From Operations | (85.69 M) | 971.22 M |
| Short Ratio | 29.34 X | 4.00 X |
| Earnings Per Share | (1.82) X | 3.12 X |
| Target Price | 18.73 | |
| Number Of Employees | 112 | 18.84 K |
| Beta | 1.12 | -0.15 |
| Market Capitalization | 643.57 M | 19.03 B |
| Total Asset | 252.01 M | 29.47 B |
| Retained Earnings | (434.93 M) | 9.33 B |
| Working Capital | 192.14 M | 1.48 B |
| Net Asset | 252.01 M |
Note: Disposition of 2089 shares by Multani Pratik S of Oric Pharmaceuticals at 3.25 subject to Rule 16b-3 [view details]
Oric Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oric . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Oric Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Oric Pharmaceuticals? Buying financial instruments such as Oric Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oric Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Municipals ETFs Thematic Idea Now
Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Municipals ETFs theme has 109 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Oric Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.